Nivolumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma

NCT03834233 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cutaneous Squamous Cell Carcinoma

Interventions

DRUG: Nivolumab

Sponsor

Instituto do Cancer do Estado de São Paulo